Lumentum Vs. Coherent: Backlog Quality Leaves Investors Spoiled for Choice

Lumentum’s quarterly revenue more than doubled to $1.006B, while Coherent’s rose 33.74% to $2.0455B, as both reported strong AI-datacenter demand and orders extending into 2027 or beyond. The article judges Lumentum’s backlog higher quality, citing scarce products, take-or-pay contracts and a forecast 39.5%–40.5% operating margin, but notes its roughly 43x forward earnings valuation versus Coherent’s 30x and customer-concentration risk. Shares fell 9.78% for LITE and 7.88% for COHR on Monday; the article does not attribute the declines to a specific catalyst.

Analysis

The key distinction is pricing power versus execution risk—not simply backlog duration. LITE’s scarcity can support near-term price and mix, but backlog converts to earnings only if constrained lasers ship on time; a capacity ramp could also reduce scarcity rents before the premium multiple is earned. Customer concentration and the OCS buyer’s internal supply option make apparent visibility less durable than contract duration suggests. COHR’s fixed-price commitments trade upside for volume visibility. If its InP expansion reaches yield and utilization targets, lower unit costs could offset locked selling prices; if not, elevated capex risks weaker returns just as AI-related demand normalizes. Either outcome could alter the relative case.

Over the next 1–3 months, shipment conversion, margin delivery, and evidence of customer-funded capacity matter more than headline order books. Over 6–18 months, InP capacity additions across the supply chain could ease bottlenecks and weaken supplier pricing power; CPO adoption and hyperscaler sourcing decisions are the larger structural swing factors. A pullback in AI infrastructure spending would expose both stocks to multiple compression, with LITE more vulnerable given its higher stated valuation. The contrarian risk to the apparent LITE quality premium is that strong margins reflect temporary scarcity, while COHR’s manufacturing investment may improve cost competitiveness. Backlog cancellation terms, customer concentration, and capacity utilization remain key items to verify.

Key Decisions for Investors

• Avoid chasing either name solely on backlog headlines after the reported selloff. Reassess after the next results: prioritize LITE only if shipments catch up while guided operating margins hold; failure on either weakens the scarcity thesis.
• For a relative-value expression, consider a small, beta-aware long LITE / short COHR position only if LITE’s shipment conversion and margin trajectory remain intact. LITE’s valuation premium leaves asymmetric downside if scarcity pricing fades; size for correlated AI-infrastructure exposure.
• Treat COHR’s capex ramp as a watch item, not an automatic negative: verify InP line yield, utilization, and incremental returns. Delays or weak utilization would support the short leg; improving output and cost performance would falsify it.
• Key reversal signals: evidence that the OCS customer is shifting supply in-house, LITE margin or shipment guidance cuts, COHR capacity milestones slipping, or hyperscaler spending/design decisions indicating slower optical or CPO adoption.